PHLDA2 and nonpapillary renal cell carcinoma: In addition, the role of only PHLDA2 expression as an independent predictor for DSS (HR 1.585, 95% CI 1.238–2.029, p < 0.001) (Table 2) and PFI (HR 1.304, 95% CI 1.059–1.604, p < 0.05) (Table 3) in ccRCC was confirmed.